Product Information

BUPROPION HCL SR 150 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0824 per EA under NDC 68084070825. Its NADAC has been published 590 times since May 6, 2015.

FDA first approved this application on Mar 24, 2009. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL SR 150 MG TABLET

bupropion hydrochloride
$0.0824per EA

Strength

150 mg/1

NDC

68084070825

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079095

FDA Approved

3/24/2009

TE Code

AB1

On Market Since

4/1/2015

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 590 times since May 6, 2015, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0824 per EA
All-time high$0.1934 (May 13, 2015)
All-time low$0.0709 (May 22, 2024)
52-week high$0.0852
52-week low$0.0805
Median price$0.1149
Average price$0.1153
Largest weekly change+20.0% (Jun 19, 2024)
Weeks tracked590
Tracking sinceMay 6, 2015

Price History

1W

-0.6%

1M

-1.9%

3M

-1.6%

6M

+0.9%

1Y

-3.3%

3Y

-4.1%

5Y

-30.2%

All

-57.4%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by American Health Packaging, is $0.0824 per EA (NDC 68084070825), effective Aug 19, 2026.

How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 57.4%. It has been tracked across 590 weekly CMS publications since May 6, 2015.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?

Since May 6, 2015, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.1934 (May 13, 2015), with a median of $0.1149 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?

Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 5% below BUPROPION HCL SR 150 MG TABLET.

Who manufactures BUPROPION HCL SR 150 MG TABLET?

BUPROPION HCL SR 150 MG TABLET (NDC 68084070825) is labeled by American Health Packaging, and CMS classifies it as a generic product.